# Commission Regulation (EC) No 478/2009 of 8 June 2009 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards monepantel (Text with EEA relevance), Division (2): A new point 2.1.8 ‘Others’ which includes the new substance ‘Monepantel’ is added to Annex III (List of pharmacologically active substances used in veterinary medicinal products for which provisional maximum residue limits have been fixed), as follows:

Extent: E+W+S+N.I.

2.
Antiparasitic agents
2.1.
Agents acting against endoparasites
‘2.1.8.
Others
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
Monepantel
Monepantel-sulfone
Caprine
700 μg/kg
Muscle
Not for use in animals producing milk for human consumption
Provisional maximum residue limit expires on 1 January 2011’
7 000 μg/kg
Fat
5 000 μg/kg
Liver
2 000 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2009/478/annex/division/2 (the official version)
Page: https://openlegislation.uk/eu-regulation-2009-478/annex/division-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.